Dr Jui Vyas

2026

• Johns, J. et al. 2026. The Dermatology Life Quality Index (DLQI) in 70 guidelines and 58 registries of 55 countries: a systematic review [Conference Abstract]. British Journal of Dermatology 195 (Supp_1) ljag086.618. (10.1093/bjd/ljag086.618)
• Lim, A. X. H. et al., 2026. The Dermatology Life Quality Index in 70 guidelines and 38 registries: a systematic review involving 55 countries: the International Standard of Care in Dermatology [Conference Abstract]. British Journal of Dermatology 195 (Supp_1) ljag151.090. (10.1093/bjd/ljag151.090)
• Vyas, J. et al. 2026. The use of artificial intelligence in dermatology systematic reviews: a comparative analysis of Elicit against human reviewers [Conference Abstract]. British Journal of Dermatology 195 (Supp1) ljag086.663. (10.1093/bjd/ljag086.663)
• Naicker, R. , Vyas, J. and Patel, S. 2026. Silence Is Not Safety: Racial Equity and Responsibility in Medical Education. The British Student Doctor Journal 9 (10.18573/bsdj.474)
• Vyas, J. et al. 2026. The use of artificial intelligence in dermatology systematic reviews: A comparative analysis of Elicit against human reviewers. Acta Dermato-Venereologica 106 adv–2025-0213. (10.2340/actadv.v106.adv-2025-0213)
• Ameen, M. et al., 2026. British Association of Dermatologists guideline for managing fungal nail infection (onychomycosis) 2026. British Journal of Dermatology

2025

• Vyas, J. et al. 2025. A systematic review of the use of the Dermatology Life Quality Index (DLQI) in routine clinical practice: evidence from 287 articles across 56 countries. Clinical and Experimental Dermatology 50 (12), pp.2456-2465. (10.1093/ced/llaf343)
• Kiss, F. and Vyas, J. 2025. Dermatological history and examination. Medicine 53 (7), pp.423-429. (10.1016/j.mpmed.2025.04.016)

2024

• Vyas, J. et al. 2024. A systematic review of 207 studies describing validation aspects of the dermatology life quality index. Acta Dermato-Venereologica 104 adv41120. (10.2340/actadv.v104.41120)
• Johns, J. R. et al. 2024. The Dermatology Life Quality Index as the primary outcome in randomized clinical trials: a systematic review. British Journal of Dermatology 191 (4), pp.497-507. (10.1093/bjd/ljae228)
• Vyas, J. et al. 2024. The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality of life instruments: A systematic review. Journal of the European Academy of Dermatology and Venereology (10.1111/jdv.20321)
• Muirhead, N. L. et al., 2024. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: impact on Quality of Life (QoL) of persons with ME/CFS. Medicina 60 (8) 1215. (10.3390/medicina60081215)
• Vyas, J. et al. 2024. A systematic review of 457 randomised controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries. British Journal of Dermatology 190 (3), pp.315-339. (10.1093/bjd/ljad079)

2023

• Clare-Kleinbussink, C. et al. 2023. Comparing the quality of life of patients and their family members with dermatological and other chronic conditions, in The Bahamas. Caribbean Medical Journal (10.48107/CMJ.2023.09.005)
• Patel, S. et al. 2023. You can’t be it if you can’t see it – the success story of the PACE project. Presented at: NETworking & Innovation in Healthcare Education. International Conference Liverpool UK 5-6 December 2023.
• Patel, S. et al. 2023. You can’t be it if you can’t see it.​ The success story of the PACE project. Presented at: NETworking & Innovation in Healthcare Education Conference 2023 Liverpool, United Kingdom 5-6 December 2023.
• Vyas, J. et al. 2023. Ethnicity and medical photographs: Patient perceptions of medical photography of dermatological conditions. Presented at: European Academy Of Dermatology And Venereology (EADV) Berlin, Germany 11-14 October 2023.

2022

• Vyas, J. et al. 2022. Impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life of people with ME/CFS and their partners and family members: an online cross-sectional survey. BMJ Open 12 (5) e058128. (10.1136/bmjopen-2021-058128)
• Patel, S. et al. 2022. Promoting academic and community excellence (PACE) project. Presented at: 7th Welsh Simulation and Teaching Symposium - Interprofessional Learning in Healthcare Education Online 6 December 2022.

2021

• Allen, J. et al., 2021. Submission to Welsh Government Consultation regarding an Anti Racist Wales. Documentation. Cardiff: Welsh Government. Available at: https://cf.sharepoint.com/:b:/t/MEDICStudentRaceEqualityTaskGroup/EeCAc5vENyJMrz6KQUbzjaABhYNt-lHjociOqHA7b3GHmw?e=ESRuG1.
• Brittain, E. et al., 2021. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): major impact on lives of both patients and family members. Medicina 57 (1) 43. (10.3390/medicina57010043)
• Akingbola, C. O. and Vyas, J. 2021. Dermatological history and examination. Medicine 49 (6), pp.343-349. (10.1016/j.mpmed.2021.03.002)

2020

• Altayeb, A. et al., 2020. Two cases of skin manifestations prior to the onset of COVID-19 respiratory symptoms. International Journal of Dermatology 59 (12), pp.1541-1542. (10.1111/ijd.15247)
• Ali, F. , Vyas, J. and Finlay, A. Y. 2020. Counting the burden: atopic dermatitis and health-related quality of life. Acta Dermato-Venereologica 100 (12) adv00161. (10.2340/00015555-3511)
• Kwan, K. and Vyas, J. 2020. A retrospective audit to assess the safety and efficacy of apremilast use in chronic plaque psoriasis. Future Healthcare Journal 7 (Suppl), pp.s47-s48. (10.7861/fhj.7.1.s47)

2019

• Luke, K. , Kiss, F. and Vyas, J. 2019. Authentic assessments: building interactive learning objects. Presented at: Cardiff University Learning & Teaching Conference 2019: Authentic Learning Cardiff, Wales, UK 11 Sept 2019. , pp.-.

2017

• Akingbola, C. O. and Vyas, J. 2017. Traction alopecia: a neglected entity in 2017. Indian Journal of Dermatology, Venereology, and Leprology 83 (6), pp.644-649. (10.4103/ijdvl.IJDVL_553_16)
• Ali, F. et al. 2017. A systematic review of the use of quality-of-life instruments in randomised controlled trials of psoriasis. British Journal of Dermatology 176 (3), pp.577-593. (10.1111/bjd.14788)
• Salek, S. et al., 2017. The value of quality of life assessment in monitoring the efficacy of interventions in psoriasis and the role of minimal clinically important difference in interpretation of scores: a systematic review. International Journal of Clinical Pharmacy 39 (1), pp.238. PE007. (10.1007/s11096-016-0404-4)

2016

• Ali, F. M. et al., 2016. Systematic review: do treatments for psoriasis meet the minimal clinically important difference for PRO measures?. Quality of Life Research 25 (S1), pp.70-71. 1004. (10.1007/s11136-016-1390-7)
• Ali, F. M. et al., 2016. The impact of interventions on quality of life in psoriasis and the concept of multiple minimal clinically important difference (MCID): a systematic review. Journal of Investigative Dermatology 136 (9:S2), pp.S166. 031. (10.1016/j.jid.2016.06.048)
• Ali, F. et al., 2016. A systematic review of the impact on quality of life of interventions for psoriasis. British Journal of Dermatology 175 (S1), pp.54. P64. (10.1111/bjd.14524)
• Ali, F. et al., 2016. Can systematic reviews help with choosing a suitable health-related quality of life measure in interventional studies of psoriasis?. International Journal of Clinical Pharmacy 38 (2), pp.565-565. PE012. (10.1007/s11096-015-0240-y)